Cimicoxib

This image is provided by the National Library of Medicine.

WikiDoc Resources for Cimicoxib
Articles
Most recent articles on Cimicoxib Most cited articles on Cimicoxib Review articles on Cimicoxib Articles on Cimicoxib in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cimicoxib Images of Cimicoxib Photos of Cimicoxib Podcasts & MP3s on Cimicoxib Videos on Cimicoxib
Evidence Based Medicine
Cochrane Collaboration on Cimicoxib Bandolier on Cimicoxib TRIP on Cimicoxib
Clinical Trials
Ongoing Trials on Cimicoxib at Clinical Trials.gov Trial results on Cimicoxib Clinical Trials on Cimicoxib at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cimicoxib NICE Guidance on Cimicoxib NHS PRODIGY Guidance FDA on Cimicoxib CDC on Cimicoxib
Books
Books on Cimicoxib
News
Cimicoxib in the news Be alerted to news on Cimicoxib News trends on Cimicoxib
Commentary
Blogs on Cimicoxib
Definitions
Definitions of Cimicoxib
Patient Resources / Community
Patient resources on Cimicoxib Discussion groups on Cimicoxib Patient Handouts on Cimicoxib Directions to Hospitals Treating Cimicoxib Risk calculators and risk factors for Cimicoxib
Healthcare Provider Resources
Symptoms of Cimicoxib Causes & Risk Factors for Cimicoxib Diagnostic studies for Cimicoxib Treatment of Cimicoxib
Continuing Medical Education (CME)
CME Programs on Cimicoxib
International
Cimicoxib en Espanol Cimicoxib en Francais
Business
Cimicoxib in the Marketplace Patents on Cimicoxib
Experimental / Informatics
List of terms related to Cimicoxib

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cimicoxib (UR-8880 trade name Cimalgex) is a non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine to treat dogs for pain and inflammation associated with osteoarthritis and for the management of pain and inflammation associated with surgery. It acts as a COX-2 inhibitor.

Synthesis

Cimicoxib synthesis:

Reaction of the imine with tosylisocyanate in the presence of potassium carbonate leads to what may be viewed as 2+3 cycloaddition of the nitrogen analogue of a ketene to form the imidazole ring.